miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway
Authors:
- 21 May 2018
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 49 (4) , 377-387
Abstract
Hypertrophic scar (HS) is a serious skin fibrotic disease characterized by the excessive proliferation of fibroblasts and often considered as a kind of benign skin tumor. microRNA-155 (miR-155) is usually served as a promising marker in antitumor therapy. In view of the similarities of hypertrophic scar and tumor, it is predicted that miR-155 may be a novel therapeutic target in clinical trials. Here we found the expression levels of miR-155 was gradually down regulated and HIF-1α was upregulated in HS tissue and HS derived fibroblasts (HFs). And cell proliferation was inhibited when miR-155 was overexpressed or HIF-1α was silenced. Moreover, overexpression of miR-155 in HFs could reduce the expression of collagens in vitro and inhibit the collagen fibers arrangement in vivo, whereas miR-155 knockdown gave opposite results. Furthermore, we found that miR-155 directly targeted the HIF-1α, which could also independently inhibit the expression of collagens in vitro and obviously improved the appearance and architecture of the rabbit ear scar in vivo when it was silencing. Finally, we found that PI3K/AKT pathway was enrolled in these processes. Together, our results indicated that miR-155 was a critical regulator in the formation and development of hypertrophic scar and might be a potential molecular target for hypertrophic scar therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81372069)
- National Natural Science Foundation of China (81601693, 81703924)
This publication has 36 references indexed in Scilit:
- The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosisJournal of Allergy and Clinical Immunology, 2017
- MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1Biomedicine & Pharmacotherapy, 2017
- Targeting microRNAs: a new action mechanism of natural compoundsOncotarget, 2016
- Fibroblast-Specific Deletion of Hypoxia Inducible Factor-1 Critically Impairs Murine Cutaneous Neovascularization and Wound HealingPlastic and Reconstructive Surgery, 2015
- Isoflurane attenuates LPS-induced acute lung injury by targeting miR-155-HIF1-alphaFrontiers in Bioscience-Landmark, 2015
- The Pivotal Role of microRNA‐155 in the Control of CancerJournal of Cellular Physiology, 2014
- Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor ImmunityCell Reports, 2012
- The complexities of microRNA regulation: mirandering around the rulesThe International Journal of Biochemistry & Cell Biology, 2010
- Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAsNature, 2005
- Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.2001